期刊
JOURNAL OF IMMUNOLOGY
卷 173, 期 12, 页码 7324-7330出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.173.12.7324
关键词
-
类别
资金
- NHLBI NIH HHS [R01HL72523] Funding Source: Medline
- NIDDK NIH HHS [R01DK54767] Funding Source: Medline
- NINDS NIH HHS [P01NS27405] Funding Source: Medline
Previously we demonstrated that SHIP-/- mice accept allogeneic bone marrow transplants (BMT) without significant acute graft-vs-host disease (GvHD). In this study we show that SHIP-/- splenocytes and lymph node cells are poor stimulators of allogeneic T cell responses that cause GvHD. Intriguingly, SHIP-/- splenocytes prime naive T cell responses to peptide epitopes, but, conversely, are partially impaired for priming T cell responses to whole Ag. However, dendritic cells (DC) purified from SHIP-/- splenocytes prime T cell responses to allogeneic targets, peptide epitopes, and whole Ag as effectively as SHIP+/+ DC. These findings point to an extrinsic effect on SHIP-/- DC that impairs priming of allogeneic T cell responses. Consistent with this extrinsic effect, we found that a dramatic expansion of myeloid suppressor cells in SHIP-/- mice impairs priming of allogeneic T cells. These findings suggest that SHIP expression or its activity could be targeted to selectively compromise T cell responses that mediate GvHD and graft rejection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据